Kailun Fei - Cancer Hospital Chinese Academy of Medical Sciences, Peking Union Medical College

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 37 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Structure-based Classification and Nomogram Prediction for Differential Inhibitor Sensitivity of EGFR Exon 19 Deletions

Wei Zhuang,Jia Zhong,Zhijie Wang,Jianchun Duan,Hua Bai,Rui Wan,Boyang Sun,Jiachen Xu,Kailun Fei,Zheng Liu,Jie Zhao,Jie Wang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations

Weihua Li,Kailun Fei,Lei Guo, Yulan Wang, Chang Shu,Jie Wang,Jianming Ying

JOURNAL OF THORACIC ONCOLOGYno. 4 (2024): 613-625

引用0浏览0WOS引用

Multi-omics Indicators of Long-Term Survival Benefits after Immune Checkpoint Inhibitor Therapy

Jie Zhao,Yiting Dong,Hua Bai,Fan Bai,Xiaoyan Yan,Jianchun Duan,Rui Wan,Jiachen Xu,Kailun Fei,Jie Wang,Zhijie Wang

Cell reports methodsno. 10 (2023): 100596-100596

引用0浏览0WOS引用

Supplementary Table S3 from TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer

Jiefei Han,Jianchun Duan,Hua Bai,Yuqi Wang,Rui Wan,Xin Wang, Si Chen,Yanhua Tian,Di Wang,Kailun Fei,Zhuoran Yao, Shuhang Wang,Zhimin Lu,Zhijie Wang,Jie Wang

crossref（2023）

引用0浏览0引用

Abnormal activation of NF-B and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid-derived suppressor cells to shape the immunosuppressive tumor immune microenvironment

Chao Wang,Kailun Fei,Lihui Liu,Jianchun Duan,Zhijie Wang,Sini Li,Jiachen Xu,Xue Zhang,Yanhua Tian,Yan Qu,Hua Bai,Jie Wang

THORACIC CANCERno. 19 (2023): 1843-1856

引用3浏览0WOS引用

Supplementary Table S2 from TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer

Jiefei Han,Jianchun Duan,Hua Bai,Yuqi Wang,Rui Wan,Xin Wang, Si Chen,Yanhua Tian,Di Wang,Kailun Fei,Zhuoran Yao, Shuhang Wang,Zhimin Lu,Zhijie Wang,Jie Wang

crossref（2023）

引用0浏览0引用

Clinical Analysis of Combined Immunotherapy in Patients with Malignant Pleural Mesothelioma

C Zhao,K L Fei, R Wan,L P Song,P C Xiang,J C Duan

wf（2023）

引用0浏览0WOS引用

Treatment of Advanced Non-Small Cell Lung Cancer with Driver Mutations: Current Applications and Future Directions

Jia Zhong,Hua Bai,Zhijie Wang,Jianchun Duan,Wei Zhuang,Di Wang,Rui Wan,Jiachen Xu,Kailun Fei,Zixiao Ma,Xue Zhang,Jie Wang

Frontiers of Medicine（2023）

引用3浏览0引用

Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study

Kailun Fei,Gang Guo,Jie Wang,Zhijie Wang,Yan Wang,Xuezhi Hao,Jia Zhong,Qinxiang Guo,Wei Guo,Wenzhong Su,Likun Zan, Jiaxi Xu,Fengwei Tan,Xiaofei Zhuang,Jianchun Duan

Frontiers in oncology（2023）

引用0浏览0WOS引用

Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity

Lihui Liu,Sini Li,Yan Qu,Hua Bai,Xiangyu Pan,Jian Wang,Zhijie Wang,Jianchun Duan,Jia Zhong,Rui Wan,Kailun Fei,Jiachen Xu,Li Yuan,Chao Wang,Pei Xue,Xue Zhang,Zixiao Ma,Jie Wang

Cell reports. Medicineno. 10 (2023): 101206-101206

引用11浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn